moving from principle to moving from principle to
play

Moving from Principle to Moving from Principle to Execution - PowerPoint PPT Presentation

Moving from Principle to Moving from Principle to Execution Execution Applications of the Risk-Dosage Relationship Kimberly Gentry Sperber, Ph.D. Today s Session s Session Today Review of the risk principle Discussion of


  1. Moving from Principle to Moving from Principle to Execution Execution Applications of the Risk-Dosage Relationship Kimberly Gentry Sperber, Ph.D.

  2. Today’ ’s Session s Session Today • Review of the risk principle • Discussion of ways to operationalize the risk principle • What does the research say about operationalizing the risk principle into practice? • What counts as dosage? • Findings from first Talbert House dosage study • Building a dosage research agenda • Questions and practitioner input

  3. The Risk Principle The Risk Principle • Identify those offenders with higher probability of re-offending • Target those offenders with higher probability of re-offending • Targeting lower risk offenders can increase recidivism • Referred to as the WHO principle

  4. 2 0 0 2 UC Study of Halfw ay 2 0 0 2 UC Study of Halfw ay Houses and CBCFs Houses and CBCFs Findings on the Risk Principle

  5. Reduced Recidivism Increased Recidivism

  6. Treatment Effects For High Risk Offenders 40 30 32 34 30 21 22 24 25 27 Probability of Reincarceration 20 10 10 12 12 12 13 13 13 15 9 8 8 10 7 6 5 3 3 3 2 0 -2 -2 -6 -5 -10 -15 -14 -20 -18 -30 -34 -40 C A C H C T E R F A T C M W C T N O A L A C L S A L S B S C F S O T M r R u E r m i a o i a o a u i u o r i l a o a o o O l E r l l l v e t o O n l c a n v a l l i v r l n c m i l l e m C t P m m r m s b n b O a k l n a a c b e h C e c i a C a F i b r R t e T h e e n s i m k l n s e d o r m d i i o s C m i p o m C n n C n a n r l n r r a B a r a T H n A l H o n C S a C c P r t u n t A / C g i u i n t D u y C n i t H H M i t H i t H a H o C / r a o H L V n a i n o l n n t P M C o r v t F i t g y i o u i C o u u i i r o i o e o u t i o O t t g g t t e u s i o u s y d m n u y o g y u V u F e r V u h C e u e A A s s s s s i a t s u a s A n T t C o O e m y k n e O A e e D c n m e g S a t u s R i i r T o A u n y t A l e C S u l a s B a n s y u r i n n p I n g n M l o e t e r t P m v c M i i u s C e y s r n e r e t y s i i R a c n i y m h k n s t m c n C t t e i C e m i i M g g T o r o o e m r n s r e a n n n G t a H e s i e n o s t h a c A r a k n o a A P o t l m r e v l l r n m s o e D e s H g y o n e r a t c p a l i C e m l a n t e i d ( n o M e t n e n e r c n y ’ s P ) r o g r a m

  7. 2 0 1 0 UC Study of Halfw ay 2 0 1 0 UC Study of Halfw ay Houses and CBCFs Houses and CBCFs Findings on the Risk Principle

  8. Treatm ent Effects for Low Risk Treatm ent Effects for Low Risk

  9. Treatm ent Effects for High Risk Treatm ent Effects for High Risk

  10. Generalizability Generalizability • To whom does the risk principle apply? – Adults – Juveniles – Males – Females – Sex Offenders – Violent Offenders

  11. Operationalizing the Risk Operationalizing the Risk Principle Principle • Separate living quarters • Separate groups • Risk-specific caseloads • Varying dosage by risk • Varying length of stay by risk

  12. W hat Does the Prior Research Say? W hat Does the Prior Research Say? • Lipsey (1999) – Meta-analysis of 200 studies on serious juvenile delinquents – Minimum length of stay of 6 months – Approximately 100 hours

  13. W hat Does the Prior Research Say? W hat Does the Prior Research Say? • Bourgon and Armstrong (2005) – 620 incarcerated males – 12 months recidivism rates – 100 hours to reduce recidivism for moderate risk OR few needs • 100 hours not enough for high risk – 200 hours for high risk OR multiple needs – 300+ hours for high risk AND multiple needs

  14. First Talbert House Dosage Study First Talbert House Dosage Study Sperber, Latessa, & Makarios (forthcoming): • Conceptual understanding of the risk principle versus operationalization of the risk principle in real world setting to achieve maximum outcome • “Can we quantify how much more service to provide high risk offenders?”

  15. The Program The Program • 100-bed CBCF for adult male felons • Prison diversion program • Average length of stay = 4 months • Serves 3 rural counties • Cognitive-behavioral treatment modality

  16. Community Correctional Center Risk Level Structure Guide Medium High High Medium Low/ Moderate Low LSI Score Range 34+ 31-33 24-30 19-23 0-18 Length of Stay Target (days) 147 133 119 105 60 Corrective Thinking 200 180 132 92 52 AOD 62 54 46 38 28 Individualized Relapse Prevention 21 Anger Management 24 24 24 24 if needed Domestic Violence 24 15 15 15 if needed Vocational* 15 15 15 15 8 Life Skills* 16 16 16 16 8 Personal Development* 10 10 10 10 if needed *not counted in dosage total Total hours available: 351 314 258 210 117

  17. Methodology Methodology • Sample size = 689 clients • Clients successfully discharged between 8/ 30/ 06 and 8/ 30/ 09 – 300 clients pre-implementation – 123 clients during implementation – 266 clients post-implementation • Excluded sex offenders • Dosage defined as number of group hours per client • Multiple measures of recidivism – arrest, conviction, reincarceration – All offenders out of program minimum of 12 months

  18. Sam ple Characteristics Sam ple Characteristics • 88.8% White • Average age 33 • 59.7% single, never married • 43.2% less than high school education • 95.5% Felony 3 or higher – Almost half Felony 5 • 80% moderate risk or higher • 88% have probability of substance abuse per SASSI

  19. Recidivism Rates by Treatment Intensity and Risk Levels low moderate high overall 0 ‐ 99 Tx hours 39 52 46 100 ‐ 199 Tx hours 26 45 81 43 200+ Tx hours 43 57 48 Average low=78, Moderate= 155 High =241

  20. Unansw ered Questions Unansw ered Questions • Is there a saturation effect? – What is maximum return on investment? • What counts as dosage? • Does dosage requirement vary by setting? – Halfway house versus CBCF • What is the impact of sequencing of dosage?

  21. Building a Dosage Research Agenda Building a Dosage Research Agenda • Treatment Dosage and Risk: An Extension and Refinement of the Appropriate Levels of Dosage by Risk Level – Makarios, Sperber, & Latessa (in process) • Treatment Dosage and Personality: Examining the Impact of Personality on the Dosage Recidivism Relationship – Latessa, Makarios, & Sperber (in process) • Examining the Dosage Recidivism Relationship in Female Offenders – Spiegel & Sperber (in process) • Frontloading Treatment Dosage and the Impact on Recidivism – Sperber and Smith (in process)

  22. Treatment Dosage and Risk: An Extension and Refinement Treatment Dosage and Risk: An Extension and Refinement of the Appropriate Levels of Dosage by Risk Level of the Appropriate Levels of Dosage by Risk Level • The limited research available on dosage indicates a broad range of treatment hours from a minimum of 200 hours to more than 300 hours of programming for high risk offenders. • Consequently, this study seeks to refine the existing extant knowledge about tailoring dosage to offender risk by testing the impact of more narrowly defined categories of dosage on recidivism for moderate and high risk offenders. • No findings yet; just recently secured recidivism data.

  23. Treatment Dosage and Personality: Examining the Impact Treatment Dosage and Personality: Examining the Impact of Personality on the Dosage Recidivism Relationship of Personality on the Dosage Recidivism Relationship • Research on the risk principle confirms that correctional practitioners should differentiate services by offender risk. • Research also confirms that these services should be based on a cognitive-behavioral modality. • At the same time, there is some research to suggest that offenders with certain personality types (e.g. neurotics) are higher risk for re-offending and may not fare as well as other personality types within cognitive behavioral programs. • If this is true, increasing cognitive behavioral dosage for high risk neurotic offenders may have a detrimental impact on recidivism for those offenders. • Consequently, this study examines personality type as a moderator of the risk dosage relationship to determine the impact on recidivism.

  24. Personality Types Personality Types • Jesness Inventory • 9 Types collapsed into 4: – Aggressives – Neurotics – Dependents – Situationals

  25. Prelim inary Findings Prelim inary Findings • Bivariate Results: – Risk positively correlated to dosage – Risk positively correlated to recidivism – Risk positively correlated to neurotic personality – Risk negatively correlated to dependent personality – Age negatively correlated to risk and to recidivism – Age positively correlated to neurotic personality and negatively correlated to aggressive personality

Recommend


More recommend